Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? J Am Coll Cardiol. 2006;48:1410 5. S10.2-9. Davis RL, Eastman D, McPhillips H, et al. Risks of congenital mal- formations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf. 2011;20:138 45. S10.2-10. Ruys TP, Maggioni A, Johnson MR, et al. Cardiac medication during pregnancy, data from the ROPAC. Int J Cardiol. 2014;177:124 8. CLINICAL STATEMENTS AND GUIDELINES S10.2-11. Beinder E, Grancay T, Menendez T, et al. Fetal sinus bradycardia and the long QT syndrome. Am J Obstet Gynecol. 2001;185:743 7. S10.2-12. Hofbeck M, Ulmer H, Beinder E, et al. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart. 1997;77:198 204. S10.2-13. Cuneo BF, Etheridge SP, Horigome H, et al. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratifi- cation of perinatal long-QT syndrome. Circ Arrhythm Electrophysiol. 2013;6:946 51. S10.2-14. Cuneo BF, Strasburger JF, Wakai RT, The natural history of fetal long QT syndrome. J Electrocardiol. 2016;49:807 13. S10.2-15. Damilakis J, Theocharopoulos N, Perisinakis K, et al. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation. 2001;104:893 7. S10.2-16. Duncker D, Haghikia A, Konig T, et al. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail. 2014;16:1331 6. 10.3. Older Patients With Comorbidities S10.3-1. Kusumoto FM, Bailey KR, Chaouki AS, et al. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e392 e414. S10.3-2. 